Healthcare Innovation Accelerator
It is aimed at Norwegian healthtech and medtech companies ready to take healthcare innovation to the next level. It offers a unique opportunity to gain valuable experience, connect with U.S. stakeholders, and refine market strategies.
Programme highlights
Programme Timeline
26.th November to 28th March 2025
- October 18: Deadline for Submissions.
- November 26: Healthcare Innovation Accelerator programme launch in Oslo*.
- December 2: Aleap workshop in Oslo.
- December 16: Virtual webinar (evening session).
- January 7: Virtual webinar (evening session).
- January 21: Virtual webinar (evening session).
- February 4: Virtual webinar (evening session).
- February 18: Virtual webinar (evening session).
- March 4: Virtual webinar (evening session).
- March 25: Market visit to DNB Offices.
- March 26: Lion’s Den Programme at NAHC 2025.
- March 24-28: Market visit to New York City.
*Please note: Companies will present their solutions at the programme launch, with further details shared upon selection.
Selection Committee
The selection committee includes representatives from Innovation Norway, Destination Medical Center, and Mayo Clinic Innovation Exchange, ensuring a fair and unbiased process.
Application Criteria
- You are the CEO or in a leadership position of a health/medtech company with U.S. potential and ambitions but not yet in the U.S. market.
- You have an MVP or prototype, potentially already in the Norwegian market.
- You have received feedback from clinical specialists who would typically work with your product.
Participation Fee: $1500
There is no fee to apply for the programme. However, if your company is selected, a programme registration fee of $1500 will be invoiced to you.
Programme Partners
The Healthcare Innovation Accelerator is powered by leading organisations dedicated to helping Norwegian companies succeed in the U.S. market:
- Innovation Norway
- DNB//Back Bay
- Mayo Clinic Innovation Exchange (MCIE)
- Destination Medical Center (DMC)
- Norwegian Consulate General in New York.
Contributors
Aleap, SopraSteria, Advokatfirmaet Thommessen and DNV.